PharmaCielo Ltd. logo

PharmaCielo Ltd. (PCLO)

Market Open
28 Jul, 16:01
TSX-V TSX-V
CA$
0. 05
0
0%
CA$
30.67M Market Cap
- P/E Ratio
0% Div Yield
8,084 Volume
0 Eps
CA$ 0.05
Previous Close
Day Range
0.05 0.05
Year Range
0.03 0.23
Want to track PCLO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 17 days

Summary

PCLO trading today higher at CA$0.05, an increase of 0% from yesterday's close, completing a monthly increase of 0% or CA$0. Over the past 12 months, PCLO stock lost -37.5%.
PCLO is not paying dividends to its shareholders.
The last earnings report, released on Jul 24, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 14, 2025.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on TSX-V (CAD).

PCLO Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

PharmaCielo Ltd. Dividends

PCLO is not paying dividends to its shareholders.

PharmaCielo Ltd. Earnings

14 Aug 2025 (In 2 weeks) Date
-
Cons. EPS
-
EPS
24 Jul 2025 Date
-
Cons. EPS
-
EPS
21 Jul 2025 Date
-
Cons. EPS
-
EPS
16 Jul 2025 Date
-
Cons. EPS
-
EPS
14 Jul 2025 Date
-
Cons. EPS
-
EPS
PCLO is not paying dividends to its shareholders.
14 Aug 2025 (In 2 weeks) Date
-
Cons. EPS
-
EPS
24 Jul 2025 Date
-
Cons. EPS
-
EPS
21 Jul 2025 Date
-
Cons. EPS
-
EPS
16 Jul 2025 Date
-
Cons. EPS
-
EPS
14 Jul 2025 Date
-
Cons. EPS
-
EPS

PharmaCielo Ltd. (PCLO) FAQ

What is the stock price today?

The current price is CA$0.05.

On which exchange is it traded?

PharmaCielo Ltd. is listed on TSX-V.

What is its stock symbol?

The ticker symbol is PCLO.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 30.67M.

When is the next earnings date?

The next earnings report will release on Aug 14, 2025.

Has PharmaCielo Ltd. ever had a stock split?

No, there has never been a stock split.

PharmaCielo Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Marc Lustig M.B.A., M.Sc. CEO
TSX-V Exchange
CA71716K1012 ISIN
CA Country
- Employees
- Last Dividend
18 Jan 2019 Last Split
- IPO Date

Overview

PharmaCielo Ltd. is a prominent entity in the medicinal cannabis industry, with a robust operation that spans cultivation, processing, production, and supply of medicinal-grade cannabis extracts, tetrahydrocannabinol (THC), and related products. The company is distinctive for its comprehensive approach to the cannabis sector, serving a diverse clientele that includes health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies primarily in Canada and Colombia. Headquartered in Toronto, Canada, PharmaCielo distinguishes itself with its international operations and a strategic partnership with Benuvia Operations, LLC. This partnership is focused on manufacturing cGMP (Current Good Manufacturing Practice) pharmaceutical-grade CBD isolate and other related products, signaling PharmaCielo's commitment to quality and regulatory compliance in the burgeoning field of medicinal cannabis.

Products and Services

  • Medicinal-grade cannabis extracts: PharmaCielo specializes in producing high-quality cannabis extracts that meet medicinal-grade standards. These extracts are derived from carefully cultivated cannabis, ensuring that they contain the desired levels of cannabinoids for therapeutic use.
  • Tetrahydrocannabinol (THC) products: The company offers products containing THC, the psychoactive component of cannabis, for medical and therapeutic applications. These products are designed to meet the needs of patients requiring THC's specific benefits.
  • Telemedicine software: In addition to its cannabis-based products, PharmaCielo provides telemedicine software to facilitate remote healthcare services. This software enables health professionals to offer consultations and services to patients in remote or underserved areas, enhancing access to healthcare.
  • cGMP pharmaceutical-grade CBD isolate: Through its strategic partnership with Benuvia Operations, LLC, PharmaCielo manufactures cGMP pharmaceutical-grade CBD isolate. This product adheres to stringent quality controls and is intended for use in various therapeutic and medicinal applications.

Contact Information

Address: 82 Richmond Street East, Toronto, ON, Canada, M5C 1P1
Phone: 416 315 8741